Gyre Therapeutics – A biotechnology company focused on organ fibrosis and inflammatory diseases

Welcome to Gyre Therapeutics

We are a biotechnology company focused on organ fibrosis and inflammatory diseases. Learn more

Our Science

Other Disease Areas

Latest news

Jan 06, 2025

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

Read more

Nov 13, 2024

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Read more

Oct 22, 2024

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

Read more

X

Previous

Next